Mashup Score:16
ReutersBiogen says ALS drug shows clinical benefit in new data analysis - 3 days
Mashup Score:16
Twitter Feed: Reuters Health
Mashup Score:13
Reuters‘Blood on your hands’ if world steps back on tackling COVID now, WHO official says - 2 days
Mashup Score:13
If rich nations think the pandemic is over, they should help lower-income countries reach that point too, a senior World Health Organization official told...
-
If rich nations think the pandemic is over, they should help lower-income countries reach that point too, a senior World Health Organization official told Reuters. https://t.co/pgcpeudx9D - view on twitter
Mashup Score:11
ReutersCOVID raises risk of long-term brain injury, large U.S. study finds - 3 days
Mashup Score:11
People who had COVID-19 are at higher risk for a host of brain injuries a year later compared with people who were never infected...
-
People who had COVID-19 are at higher risk for a host of brain injuries a year later compared with people who were never infected by the coronavirus, a finding that could affect millions of Americans, U.S. researchers reported on Thursday. https://t.co/IahnBfrRAC - view on twitter
Mashup Score:11
ReutersWHO ‘strongly advises against’ use of two COVID treatments - 1 week
Mashup Score:11
Two COVID-19 antibody therapies are no longer recommended by the World Health Organization (WHO), on the basis that Omicron and the variant’s latest offshoots...
-
Two COVID-19 antibody therapies are no longer recommended by the World Health Organization (WHO), on the basis that Omicron and the variant's latest offshoots have likely rendered them obsolete. https://t.co/WUQZ32QJN9 - view on twitter
Mashup Score:9
ReutersBiogen says ALS drug shows clinical benefit in new data analysis - 4 days
Mashup Score:9
Longer-term use and early initiation of Biogen Inc’s experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) was effective in slowing disease...
-
Longer-term use and early initiation of Biogen Inc's experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) was effective in slowing disease progression, according to a new analysis by the company published on Wednesday. https://t.co/nI6t4qVHTU - view on twitter
Mashup Score:9
ReutersEU health regulator says COVID pandemic not over - 5 days
Mashup Score:9
An official at the European Union’s drugs regulator said on Tuesday the COVID-19 pandemic was not over, contradicting U.S. President Joe Biden, and that...
-
An official at the European Union's drugs regulator said on Tuesday the COVID-19 pandemic was not over, contradicting U.S. President Joe Biden, and that a planned vaccination campaign in the region during the cold season was key to fighting it. https://t.co/7UgtqwjYZm - view on twitter
Mashup Score:8
ReutersU.S. cutting global donations of Pfizer COVID shots as demand slows - 2 days
Mashup Score:8
The United States is significantly cutting back the number of Pfizer /BioNTech COVID-19 vaccine doses it will buy for donation to poorer nations this...
-
The United States is significantly cutting back the number of Pfizer /BioNTech COVID-19 vaccine doses it will buy for donation to poorer nations this year, Pfizer said on Thursday, citing diminished demand for the shots in those countries. https://t.co/cEjfcjJdJS - view on twitter
Mashup Score:7
ReutersBrazil approves Pfizer vaccine for children as young as six months - 1 week
Mashup Score:7
Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years,...
-
Brazilian national health regulator Anvisa has approved the COVID-19 vaccine produced by Pfizer and BioNTech for children aged between six months and four years, the government body said in a statement Friday night. https://t.co/wsuSNdWKiv - view on twitter
Mashup Score:6
ReutersCOVID raises risk of long-term brain injury, large U.S. study finds - 3 days
Mashup Score:6
People who had COVID-19 are at higher risk for a host of brain injuries a year later compared with people who were never infected...
-
People who had COVID-19 are at higher risk for a host of brain injuries a year later compared with people who were never infected by the coronavirus, a finding that could affect millions of Americans, U.S. researchers reported on Thursday. https://t.co/mIizeJBePE - view on twitter
Mashup Score:6
ReutersPfizer to supply up to 6 mln COVID pill courses for lower income countries - 3 days
Mashup Score:6
Pfizer Inc said on Thursday it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low-...
-
Pfizer Inc said on Thursday it would supply up to 6 million courses of its COVID-19 antiviral treatment to NGO Global Fund for low- and middle-income countries that seeks to address worldwide disparities in COVID response. https://t.co/h6eLknZkph - view on twitter
Longer-term use and early initiation of Biogen Inc’s experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) was effective in slowing disease...
Longer-term use and early initiation of Biogen Inc's experimental treatment for an inherited form of amyotrophic lateral sclerosis (ALS) was effective in slowing disease progression, according to a new analysis by the company published on Wednesday. https://t.co/TW0CA9vUX7 - view on twitter